Showing 2391-2400 of 2652 results for "".
- As COVID-19 Shutters Practices Virtual Doc-Patient Activity Soarshttps://modernod.com/news/as-covid-19-shutters-practices-virtual-doc-patient-activity-soars/2477685/A new report shows the enormous increase in online messages and virtual interactions physicians have been having with their patients―out of necessity―since the beginning of the COVID-19 pandemic, according to a Medscape report. The
- Higher Rates of COVID-19 Infection and Death for People With Parkinson Diseasehttps://modernod.com/news/higher-rates-of-covid-19-infection-and-death-for-people-with-parkinson-disease/2477683/A paper accepted for publication in Movement Disorders suggests that people with Parkinson disease (PD) with longer disease duration (mean 12.7 years) may be more susceptible to infection with the SARS-CoV2 virus (COVID-19), according to an
- Market Scope: New Refractive Atlas Identifies Location of LVC Candidates and Refractive Surgeonshttps://modernod.com/news/market-scope-new-refractive-atlas-identifies-location-of-lvc-candidates-and-refractive-surgeons/2477682/The metro areas of New York, Los Angeles, Dallas, and Chicago account for 14 percent of the population age 20 to 44 in the US and 9.3 percent of the US population with refractive error, according to a Market Scope report. However, on a per capita share basis, most of the metro areas in Col
- Quest Diagnostics Launches First Consumer-Ordered COVID-19 Antibody Testhttps://modernod.com/news/quest-diagnostics-launches-first-consumer-ordered-covid-19-antibody-test/2477674/For about $120, anyone can get now get a COVID-19 antibody test from Quest Diagnostics. The lab company announced Tuesday it launched the first consumer-ordered test—yes, that means there’s no doctor referral needed—to allow patients to check whether they have the antibodies that indicate t
- Congress Urges FDA to Better Police, Evaluate COVID-19 Antibody Testshttps://modernod.com/news/congress-urges-fda-to-better-police-evaluate-covid-19-antibody-tests/2477665/Members of Congress have called on the FDA to re-evaluate its stance toward COVID-19 antibody tests. Since mid-March, the agency has allowed diagnostic developers to bring their products to market without any outside evaluation that the results they produce are accurate, according to a
- Ziemer Receives CE Mark Clearance For Two New Applications For the Femto LDV Z8 Laser Platformhttps://modernod.com/news/ziemer-receives-ce-mark-clearance-for-two-new-applications-for-the-femto-ldv-z8-laser-platform/2477654/After several years of development, Ziemer has received CE clearance for its new lenticule application called CLEAR (Corneal Lenticule Extraction for Advanced Refractive Correction). The new proprietary application is
- David Rostov Joins CorneaGen as Chief Financial Officerhttps://modernod.com/news/david-rostov-joins-corneagen-as-chief-financial-officer/2477648/CorneaGen announced that David Rostov has joined the company as chief financial officer. Mr. Rostov has more than 20 years of C-suite experience in scaling fast-growing technology companies, mergers and acquisitions and corpor
- Lilly Partners With NIH to Test Olumiant in Patients Hospitalized With COVID-19https://modernod.com/news/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/2477574/Drug companies worldwide are testing existing medicines as potential treatments for COVID-19—plus working on new therapeutics—with few answers yet. Now, Eli Lilly is among the latest to kick off a trial through a partnership with federal health officials, according t
- Staar Surgical Provides COVID-19 Business Updatehttps://modernod.com/news/staar-surgical-provides-covid-19-business-update/2477570/Staar Surgical Company provided a business update relating to the evolving COVID-19 global health care concern. “We have made the decision to get out in front of our traditional earnings call communications to let you know how Staar is faring during the COVID-19 pandemic. It is clear that
- Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injectionshttps://modernod.com/news/breakthrough-technology-used-to-discover-eye-damage-from-repeated-intravitreal-injections/2477567/In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections. The findings, published in the April issue of Retina, suggest that repeated use of these i